Search
- Mar 22
The $100 Genome: Visiting Ultima Genomics and seeing the UG 100 sequencer
BiotechTV visited the Freemont, CA headquarters of Ultima Genomics and spoke with CEO Gilad Almogy about their approach.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A